Press Releases - The Aurum Institute

Improving availability of patient-friendly tuberculosis preventive therapy

Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course

A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...
IMPAACT4TB Project statement responding to the WHO Global TB Report 2021

IMPAACT4TB Welcomes Gains in TB Prevention Among People Living With HIV, But Calls for Urgent Action to Address TB Prevention Deficits Among Children and Household Contacts of People Affected by TB ...
IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY AND CAMBRIDGE, MA — MAY 18,...
Unitaid and partners cut cost of portable AI-compatible X-ray device, bringing TB screening closer to communities

May 20, 2025: Unitaid and the Clinton Health Access Initiative (CHAI) today announced a new agreement to dramatically lower the price and improve access to a battery-operated, ultraportable digital ch...
Aurum Institute Ghana: Making significant contributions towards Ghana’s healthcare services.

Aurum Institute Ghana, a proudly African organisation working to advance health science and innovation has reached a milestone of five years of operation in Ghana.  Aurum Ghana is part of T...
The Aurum Institute Welcomes Prof. Vinodh Edward as Group Chief Operating Officer

The Aurum Institute Board is thrilled to announce Prof. Vinodh Edward's appointment as the new Group Chief Operating Officer (GCOO), effective 1 January 2025. This strategic move marks a significant m...

Improving availability of patient-friendly tuberculosis preventive therapy

Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course

IMPAACT4TB Project statement responding to the WHO Global TB Report 2021

IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program

Unitaid and partners cut cost of portable AI-compatible X-ray device, bringing TB screening closer to communities

Aurum Institute Ghana: Making significant contributions towards Ghana’s healthcare services.

The Aurum Institute Welcomes Prof. Vinodh Edward as Group Chief Operating Officer

Popular Tags

Most Read

Recent Posts